A Nasal Treatment for COVID-19

Status:
Not yet recruiting

Trial end date:
2023-12-31

Target enrollment:

Participant gender:

The goal of this study is to test an investigational new inhaled medication called Optate.

Early Phase 1

Indiana University

Glycine